Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pact
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
- Latest
- Trending
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
NFT activity on the XRP Ledger (XRPL) has surged, with 3.4 million mints in Q4. On-chain transactions and wallet numbers ...
Amazon founder Jeff Bezos has sold $2 billion worth of company shares, according to a filing with the SEC. He ...
Ethereum's recent technological upgrade Dencun could push its price higher, says analyst Michael van de Poppe. Dencun aims to enhance ...
Senator Bill Hagerty (R-Tenn.) introduces Protecting Innovation in Investment Act to safeguard affordable access to financial markets, preventing a detrimental ...
Prometheum Inc., the only crypto securities platform in the US with regulatory approval, plans to offer custody services for Ethereum's ...
The SEC delays decision on spot Ethereum ETF application, further fueling speculation in the crypto community. Approval of these investment ...
Europe dominates the global market for Ethereum ETFs with an 81.4% market share, while Canada commands a 16.6% share. The ...
US SEC delays decision on BlackRock's Spot Ethereum ETF, with new deadline set for March 10, 2024. Bloomberg analyst expects ...
The Bitwise Bitcoin ETF (BITB) sets a new standard for transparency with its decision to publish on-chain addresses of its ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.